MacroGenics, Inc. - Enterprise Value

The Enterprise Value as of August 2026 (TTM) for MacroGenics, Inc. (MGNX) is 218.21M

According to MacroGenics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 218.21M. This represents a change of 107.36% compared to the average of 105.23M of the last 4 quarters.

MacroGenics, Inc. (MGNX) Historical Enterprise Value (quarterly & annually)

How has MGNX Enterprise Value performed in the past?

The mean historical Enterprise Value of MacroGenics, Inc. over the last ten years is 481.52M. The current 218.21M Enterprise Value has changed 4.43% with respect to the historical average. Over the past ten years (40 quarters), MGNX's Enterprise Value was at its highest in in the March 2021 quarter at 1.62B. The Enterprise Value was at its lowest in in the March 2025 quarter at -28137922.95.

MacroGenics, Inc. (MGNX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MacroGenics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MacroGenics, Inc. (MGNX) Average Enterprise Value

How has MGNX Enterprise Value performed in the past?

The current Enterprise Value of MacroGenics, Inc. (MGNX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

MacroGenics, Inc. (MGNX) Enterprise Value vs. Peers

How is MGNX’s Enterprise Value compared to its peers?

MacroGenics, Inc.’s Enterprise Value is less than Ovid Therapeutics Inc. (390.79M), greater than Context Therapeutics Inc. (3.88M), greater than Clene Inc. (71.26M), greater than Whitehawk Therapeutics Inc (167.97M), less than Shattuck Labs, Inc. (270.63M), greater than Connect Biopharma Holdings Limited (95.83M), greater than Oramed Pharmaceuticals Inc. (166.00M), less than Zentalis Pharmaceuticals, Inc. (355.90M), greater than Coya Therapeutics, Inc. (31.12M), greater than InflaRx N.V. (96.15M),

Build a custom stock screener for MacroGenics, Inc. (MGNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MacroGenics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MacroGenics, Inc. (MGNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MacroGenics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.